Makita Corporation (MKTAY)

Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	236,547	253,279	196,645	162,720	71,057	148,640
Cash & Short-Term Investments	236,547	253,279	196,645	162,720	71,057	148,640
Cash Growth	17.81%	28.80%	20.85%	129.00%	-52.20%	3.63%
Receivables	105,662	105,831	116,267	110,884	117,541	95,691
Inventory	347,072	338,116	345,491	453,752	475,128	267,547
Other Current Assets	49,346	59,211	35,232	26,083	21,233	28,450
Total Current Assets	738,627	756,437	693,635	753,439	684,959	540,328
Property, Plant & Equipment	266,991	266,609	277,248	265,638	243,636	189,366
Long-Term Investments	-	55,782	55,049	51,946	56,579	64,960
Goodwill	-	721	721	721	721	721
Other Intangible Assets	9,442	8,853	9,485	9,706	9,364	8,643
Long-Term Deferred Tax Assets	18,488	18,123	19,670	17,901	12,238	8,860
Other Long-Term Assets	56,080	-	-	-	-	-
Total Assets	1,089,628	1,106,525	1,055,808	1,099,351	1,007,497	812,878
Accounts Payable	56,785	54,628	49,987	41,767	67,274	59,792
Short-Term Debt	7,294	10,152	19,891	186,390	79,674	2,612
Current Income Taxes Payable	11,079	13,003	9,113	3,757	14,767	11,218
Other Current Liabilities	59,466	61,215	66,484	59,679	62,450	48,176
Total Current Liabilities	134,624	138,998	145,475	291,593	224,165	121,798
Long-Term Leases	15,619	-	-	-	-	-
Long-Term Deferred Tax Liabilities	14,020	14,341	12,546	12,576	11,888	10,954
Other Long-Term Liabilities	2,258	17,506	19,312	16,653	15,754	13,394
Total Liabilities	169,798	174,030	180,602	323,652	254,967	149,552
Common Stock	23,805	23,805	23,805	23,805	23,805	23,805
Additional Paid-In Capital	46,031	46,014	45,607	45,606	45,585	45,559
Retained Earnings	727,624	732,556	669,359	629,314	640,577	588,644
Treasury Stock	-36,876	-21,470	-21,501	-11,528	-11,540	-11,543
Comprehensive Income & Other	152,583	145,100	150,886	82,050	47,917	11,390
Total Common Equity	913,167	926,005	868,156	769,247	746,344	657,855
Minority Interest	6,663	6,490	7,050	6,452	6,186	5,471
Shareholders' Equity	919,830	932,495	875,206	775,699	752,530	663,326
Total Liabilities & Equity	1,089,628	1,106,525	1,055,808	1,099,351	1,007,497	812,878
Total Debt	22,913	10,152	19,891	186,390	79,674	2,612
Net Cash (Debt)	213,634	243,127	176,754	-23,670	-8,617	146,028
Net Cash Growth	23.53%	37.55%	-	-	-	7.82%
Net Cash Per Share	795.17	903.71	655.90	-87.17	-31.73	537.81
Filing Date Shares Outstanding	265.52	266.58	269.02	270.51	271.53	271.53
Total Common Shares Outstanding	265.52	269.04	269.02	271.54	271.53	271.53
Working Capital	604,003	617,439	548,160	461,846	460,794	418,530
Book Value Per Share	3439.11	3441.88	3227.06	2832.89	2748.64	2422.80
Tangible Book Value	903,725	916,431	857,950	758,820	736,259	648,491
Tangible Book Value Per Share	3403.55	3406.29	3189.12	2794.49	2711.50	2388.31

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.